Wealthcare Advisory Partners LLC Mannkind Corp Transaction History

Wealthcare Advisory Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.45 $324 - $490	-90 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$3.14 - $6.14 $282 - $552	90 New	90 $0
Q2 2020 Jul 29, 2020	SELL	$0.94 - $2.21 $230 - $541	-245 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$0.84 - $1.76 $130 - $272	155 Added 172.22%	245 $0
Q4 2017 Feb 14, 2018	BUY	$2.28 - $6.71 $205 - $603	90	90 $0

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.65B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.